These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15719273)

  • 1. Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases.
    Aguirre-Cruz L; Charuel JL; Carpentier AF; Benyahia B; Delattre JY; Musset L
    J Neurooncol; 2005 Jan; 71(1):39-41. PubMed ID: 15719273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic neurological syndromes associated with Yo, Hu, and Ri autoantibodies.
    Bradwell AR
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):19-29. PubMed ID: 11064823
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of antineuronal antibodies from patients with paraneoplastic neurological syndrome on primary-cultured neurons.
    Tanaka K; Ding X; Tanaka M
    J Neurol Sci; 2004 Jan; 217(1):25-30. PubMed ID: 14675605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.
    Uchuya M; Graus F; Vega F; Reñé R; Delattre JY
    J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):388-92. PubMed ID: 8774401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Hu antibodies may indicate a positive response to chemotherapy in paraneoplastic syndrome secondary to small cell lung cancer.
    Douglas CA; Ellershaw J
    Palliat Med; 2003 Oct; 17(7):638-9. PubMed ID: 14594156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies.
    Dropcho EJ; King PH
    Ann Neurol; 1994 Aug; 36(2):200-5. PubMed ID: 8053656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological mechanisms in paraneoplastic peripheral neuropathy.
    Antoine JC
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):61-72. PubMed ID: 11064827
    [No Abstract]   [Full Text] [Related]  

  • 8. [The value of specific neuronal anti-Hu antibody in the early diagnosis of small cell lung cancer].
    Wang G; Chen Q; Zhu Y; Ke D; Qian W; Song W
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):732-5. PubMed ID: 12622892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic antineuronal antibodies in patients with systemic autoimmune diseases.
    Benyahia B; Amoura Z; Rousseau A; Le Clanche C; Carpentier A; Piette JC; Delattre JY
    J Neurooncol; 2003 May; 62(3):349-51. PubMed ID: 12777089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy.
    Sillevis Smitt P; Grefkens J; de Leeuw B; van den Bent M; van Putten W; Hooijkaas H; Vecht C
    J Neurol; 2002 Jun; 249(6):745-53. PubMed ID: 12111309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paraneoplastic neurological autoimmune diseases].
    Voltz R
    Dtsch Med Wochenschr; 2004 Aug; 129(33):1743-6. PubMed ID: 15295685
    [No Abstract]   [Full Text] [Related]  

  • 12. Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes.
    Lladó A; Mannucci P; Carpentier AF; Paris S; Blanco Y; Saiz A; Delattre JY; Graus F
    Neurology; 2004 Nov; 63(10):1947-9. PubMed ID: 15557520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dysphagia and constipation as clinical manifestations of anti-Hu paraneoplastic syndrome].
    Guardiola H; Vilaseca B; Martí S; de la Torre N
    Med Clin (Barc); 2004 Sep; 123(10):398-9. PubMed ID: 15482710
    [No Abstract]   [Full Text] [Related]  

  • 14. Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration.
    Amyes E; Curnow J; Stark Z; Corlett L; Sutton I; Vincent A
    J Neuroimmunol; 2001 Mar; 114(1-2):259-64. PubMed ID: 11240040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of antineuronal autoantibodies in a series of neurological patients.
    Vianello M; Vitaliani R; Pezzani R; Nicolao P; Betterle C; Keir G; Thompson EJ; Tavolato B; Scaravilli F; Giometto B
    J Neurol Sci; 2004 May; 220(1-2):29-36. PubMed ID: 15140602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsoclonus-myoclonus and antineuronal antibodies in neuroblastoma.
    Blatt J
    Pediatr Hematol Oncol; 1996; 13(5):iii-v. PubMed ID: 10897807
    [No Abstract]   [Full Text] [Related]  

  • 17. [Abdominal complaints and neurological symptoms as an early sign of lung cancer: a manifestation of the anti-Hu syndrome].
    Wymenga AN; Slebos DJ; van der Naalt J; van Putten JW; Peters FT
    Ned Tijdschr Geneeskd; 2003 Mar; 147(13):616-9. PubMed ID: 12701397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis of paraneoplastic neurological syndromes].
    Tanaka K
    Brain Nerve; 2010 Apr; 62(4):309-18. PubMed ID: 20420170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limbic encephalitis and small cell lung cancer. Clinical and immunological features.
    Alamowitch S; Graus F; Uchuya M; Reñé R; Bescansa E; Delattre JY
    Brain; 1997 Jun; 120 ( Pt 6)():923-8. PubMed ID: 9217677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome.
    Michalak S; Cofta S; Piatek A; Rybacka J; Wysocka E; Kozubski W
    Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):156-61. PubMed ID: 20156748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.